{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NPR-C", "adipose tissue", "co-morbiditie", "heart failure", "heart failure with preserved ejection fraction", "natriuretic peptide receptor C", "natriuretic peptides", "obesity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34093235", "DateRevised": {"Year": "2021", "Month": "06", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "21"}], "Language": ["eng"], "ELocationID": ["674254", "10.3389/fphys.2021.674254"], "Journal": {"ISSN": "1664-042X", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in physiology", "ISOAbbreviation": "Front Physiol"}, "ArticleTitle": "Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).", "Pagination": {"StartPage": "674254", "MedlinePgn": "674254"}, "Abstract": {"AbstractText": ["Heart failure (HF) with preserved ejection fraction (HFpEF) is a major public health problem with cases projected to double over the next two decades. There are currently no US Food and Drug Administration-approved therapies for the health-related outcomes of HFpEF. However, considering the high prevalence of this heterogeneous syndrome, a directed therapy for HFpEF is one the greatest unmet needs in cardiovascular medicine. Additionally, there is currently a lack of mechanistic understanding about the pathobiology of HFpEF. The phenotyping of HFpEF patients into pathobiological homogenous groups may not only be the first step in understanding the molecular mechanism but may also enable the development of novel targeted therapies. As obesity is one of the most common comorbidities found in HFpEF patients and is associated with many cardiovascular effects, it is a viable candidate for phenotyping. Large outcome trials and registries reveal that being obese is one of the strongest independent risk factors for developing HFpEF and that this excess risk may not be explained by traditional cardiovascular risk factors. Recently, there has been increased interest in the intertissue communication between adipose tissue and the heart. Evidence suggests that the natriuretic peptide clearance receptor (NPR-C) pathway may play a role in the development and pathobiology of obesity-related HFpEF. Therefore, therapeutic manipulations of the NPR-C pathway may represent a new pharmacological strategy in the context of underlying molecular mechanisms."], "CopyrightInformation": "Copyright \u00a9 2021 Egom."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut du Savoir Montfort, H\u00f4pital Montfort, University of Ottawa, Ottawa, ON, Canada."}, {"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Egom", "ForeName": "Emmanuel Eroume A", "Initials": "EEA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Physiol", "NlmUniqueID": "101549006", "ISSNLinking": "1664-042X"}, "CoiStatement": "The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Agabiti-Rosei E., Muiesan M. L. (2002). Left ventricular hypertrophy and heart failure in women. J. Hypertens Suppl. 20 S34\u2013S38.", "ArticleIdList": ["12183849"]}, {"Citation": "Al-Khatib S. M., Benjamin E. J., Albert C. M., Alonso A., Chauhan C., Chen P. S., et al. (2020). Advancing research on the complex interrelations between atrial fibrillation and heart failure: a report from a US national heart, lung, and blood institute virtual workshop. Circulation 141 1915\u20131926. 10.1161/circulationaha.119.045204", "ArticleIdList": ["10.1161/circulationaha.119.045204", "PMC7291844", "32511001"]}, {"Citation": "Ather S., Chan W., Bozkurt B., Aguilar D., Ramasubbu K., Zachariah A. A., et al. (2012). Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J. Am. Coll. Cardiol. 59 998\u20131005. 10.1016/j.jacc.2011.11.040", "ArticleIdList": ["10.1016/j.jacc.2011.11.040", "PMC4687406", "22402071"]}, {"Citation": "Belo N. O., Sairam M. R., Dos Reis A. M. (2008). Impairment of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for obesity-associated hypertension in menopause. Endocrinology 149 1399\u20131406. 10.1210/en.2007-0572", "ArticleIdList": ["10.1210/en.2007-0572", "18063689"]}, {"Citation": "Bordicchia M., Ceresiani M., Pavani M., Minardi D., Polito M., Wabitsch M., et al. (2016). Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway. Am. J. Physiol. Regul. Integr. Comp. Physiol. 311 R104\u2013R114. 10.1152/ajpregu.00499.2015", "ArticleIdList": ["10.1152/ajpregu.00499.2015", "27101299"]}, {"Citation": "Bordicchia M., Liu D., Amri E. Z., Ailhaud G., Dess\u00ec-Fulgheri P., Zhang C., et al. (2012). Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 122 1022\u20131036. 10.1172/jci59701", "ArticleIdList": ["10.1172/jci59701", "PMC3287224", "22307324"]}, {"Citation": "Calvieri C., Rubattu S., Volpe M. (2012). Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. J. Mol. Med. 90 5\u201313. 10.1007/s00109-011-0801-z", "ArticleIdList": ["10.1007/s00109-011-0801-z", "21826523"]}, {"Citation": "Casco V. H., Veinot J. P., Kuroski de Bold M. L., Masters R. G., Stevenson M. M., de Bold A. J. (2002). Natriuretic peptide system gene expression in human coronary arteries. J. Histochem. Cytochem. 50 799\u2013809. 10.1177/002215540205000606", "ArticleIdList": ["10.1177/002215540205000606", "12019296"]}, {"Citation": "Chamberlain A. M., Redfield M. M., Alonso A., Weston S. A., Roger V. L. (2011). Atrial fibrillation and mortality in heart failure: a community study. Circ. Heart Fail. 4 740\u2013746. 10.1161/circheartfailure.111.962688", "ArticleIdList": ["10.1161/circheartfailure.111.962688", "PMC3222889", "21920917"]}, {"Citation": "Christoffersen C., Bartels E. D., Nielsen L. B. (2006). Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice. Eur. J. Clin. Invest. 36 69\u201375. 10.1111/j.1365-2362.2006.01596.x", "ArticleIdList": ["10.1111/j.1365-2362.2006.01596.x", "16436087"]}, {"Citation": "Clerico A., Zaninotto M., Passino C., Plebani M. (2018). Obese phenotype and natriuretic peptides in patients with heart failure with preserved ejection fraction. Clin. Chem. Lab. Med. 56 1015\u20131025. 10.1515/cclm-2017-0840", "ArticleIdList": ["10.1515/cclm-2017-0840", "29381470"]}, {"Citation": "Cou\u00e9 M., Badin P. M., Vila I. K., Laurens C., Louche K., Marqu\u00e8s M. A., et al. (2015). Defective natriuretic peptide receptor signaling in skeletal muscle links obesity to type 2 diabetes. Diabetes 64 4033\u20134045. 10.2337/db15-0305", "ArticleIdList": ["10.2337/db15-0305", "26253614"]}, {"Citation": "Crandall D. L., Ferraro G. D., Cervoni P. (1989). Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide. Proc. Soc. Exp. Biol. Med. 191 352\u2013356. 10.3181/00379727-191-42932", "ArticleIdList": ["10.3181/00379727-191-42932", "2528148"]}, {"Citation": "Daniels L. B., Clopton P., Bhalla V., Krishnaswamy P., Nowak R. M., McCord J., et al. (2006). How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the breathing not properly multinational study. Am. Heart J. 151 999\u20131005. 10.1016/j.ahj.2005.10.011", "ArticleIdList": ["10.1016/j.ahj.2005.10.011", "16644321"]}, {"Citation": "de Andrade E. N., Gon\u00e7alves G. K., de Oliveira T. H., Santos C. S., Souza C. L., Firmes L. B., et al. (2011). Natriuretic peptide system: a link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats. Regul. Pept. 167 149\u2013155. 10.1016/j.regpep.2010.12.009", "ArticleIdList": ["10.1016/j.regpep.2010.12.009", "21237215"]}, {"Citation": "Del Ry S., Cabiati M., Bianchi V., Randazzo E., Peroni D., Clerico A., et al. (2020). C-type natriuretic peptide plasma levels and whole blood mRNA expression show different trends in adolescents with different degree of endothelial dysfunction. Peptides 124:170218. 10.1016/j.peptides.2019.170218", "ArticleIdList": ["10.1016/j.peptides.2019.170218", "31794787"]}, {"Citation": "Dess\u00ec-Fulgheri P., Sarzani R., Serenelli M., Tamburrini P., Spagnolo D., Giantomassi L., et al. (1999). Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 33 658\u2013662. 10.1161/01.hyp.33.2.658", "ArticleIdList": ["10.1161/01.hyp.33.2.658", "10024323"]}, {"Citation": "Dess\u00ec-Fulgheri P., Sarzani R., Tamburrini P., Moraca A., Espinosa E., Cola G., et al. (1997). Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J. Hypertens 15 1695\u20131699. 10.1097/00004872-199715120-00074", "ArticleIdList": ["10.1097/00004872-199715120-00074", "9488224"]}, {"Citation": "D\u00edez J. (2017). Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy. Eur. J. Heart Fail. 19 167\u2013176.", "ArticleIdList": ["PMC5297869", "27766748"]}, {"Citation": "Dobrev D., Nattel S. (2010). New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 375 1212\u20131223. 10.1016/S0140-6736(10)60096-7", "ArticleIdList": ["10.1016/S0140-6736(10)60096-7", "20334907"]}, {"Citation": "Egom E. E. (2015). BNP and heart failure: preclinical and clinical trial data. J. Cardiovasc. Transl. Res. 8 149\u2013157. 10.1007/s12265-015-9619-3", "ArticleIdList": ["10.1007/s12265-015-9619-3", "25771949"]}, {"Citation": "Egom E. E. (2019). Pulmonary arterial hypertension due to NPR-C mutation: a novel paradigm for normal and pathologic remodeling? Int. J. Mol. Sci. 20:3063. 10.3390/ijms20123063", "ArticleIdList": ["10.3390/ijms20123063", "PMC6628360", "31234560"]}, {"Citation": "Egom E. E., Feridooni T., Hotchkiss A., Kruzliak P., Pasumarthi K. B. (2015a). Mechanisms of renal hyporesponsiveness to BNP in heart failure. Can. J. Physiol. Pharmacol. 93 399\u2013403. 10.1139/cjpp-2014-0356", "ArticleIdList": ["10.1139/cjpp-2014-0356", "25881664"]}, {"Citation": "Egom E. E., Vella K., Hua R., Jansen H. J., Moghtadaei M., Polina I., et al. (2015b). Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C. J. Physiol. 593 1127\u20131146. 10.1113/jphysiol.2014.283135", "ArticleIdList": ["10.1113/jphysiol.2014.283135", "PMC4358675", "25641115"]}, {"Citation": "Egom E. E., Feridooni T., Pharithi R. B., Khan B., Shiwani H. A., Maher V., et al. (2017a). A natriuretic peptides clearance receptor\u2019s agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: new hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomed. Pharmacother. 93 1144\u20131150. 10.1016/j.biopha.2017.07.027", "ArticleIdList": ["10.1016/j.biopha.2017.07.027", "28738523"]}, {"Citation": "Egom E. E., Feridooni T., Pharithi R. B., Khan B., Shiwani H. A., Maher V., et al. (2017b). Erratum: new insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int. J. Physiol. Pathophysiol. Pharmacol. 9:164.", "ArticleIdList": ["PMC5698694", "29218116"]}, {"Citation": "Egom E. E., Feridooni T., Pharithi R. B., Khan B., Shiwani H. A., Maher V., et al. (2017c). New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int. J. Physiol. Pathophysiol. Pharmacol. 9 112\u2013118.", "ArticleIdList": ["PMC5592245", "28951773"]}, {"Citation": "Egom E. E., Maher V., El Hiani Y. (2019). Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure. Int. J. Cardiol. 281 172\u2013178. 10.1016/j.ijcard.2018.06.001", "ArticleIdList": ["10.1016/j.ijcard.2018.06.001", "29885823"]}, {"Citation": "Egom E. E., Pharithi R. B., Shiwani H. A., Khan B., Kruzliak P., El-Hiani Y., et al. (2018). Time to redefine body mass index categories in chronic diseases? spotlight on obesity paradox. Int. J. Food Sci. Nutr. 69 513\u2013523. 10.1080/09637486.2017.1389859", "ArticleIdList": ["10.1080/09637486.2017.1389859", "29063824"]}, {"Citation": "Farr\u00e9 N., Arany\u00f3 J., Enjuanes C., Verd\u00fa-Rotellar J. M., Ruiz S., Gonzalez-Robledo G., et al. (2015). Differences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activation. Int. J. Cardiol. 181 120\u2013126. 10.1016/j.ijcard.2014.12.025", "ArticleIdList": ["10.1016/j.ijcard.2014.12.025", "25497534"]}, {"Citation": "Finck B. N., Kelly D. P. (2006). PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116 615\u2013622.", "ArticleIdList": ["PMC1386111", "16511594"]}, {"Citation": "Fonarow G. C., Srikanthan P., Costanzo M. R., Cintron G. B., Lopatin M. (2007). An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry. Am. Heart J. 153 74\u201381. 10.1016/j.ahj.2006.09.007", "ArticleIdList": ["10.1016/j.ahj.2006.09.007", "17174642"]}, {"Citation": "Frohlich E. D., Apstein C., Chobanian A. V., Devereux R. B., Dustan H. P., Dzau V., et al. (1992). The heart in hypertension. N. Engl. J. Med. 327 998\u20131008. 10.1056/NEJM199210013271406", "ArticleIdList": ["10.1056/NEJM199210013271406", "1518549"]}, {"Citation": "Fukui A., Takahashi N., Nakada C., Masaki T., Kume O., Shinohara T., et al. (2013). Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Circ. Arrhythm Electrophysiol. 6 402\u2013409. 10.1161/CIRCEP.111.000104", "ArticleIdList": ["10.1161/CIRCEP.111.000104", "23406575"]}, {"Citation": "Furuya M., Miyazaki T., Honbou N., Kawashima K., Ohno T., Tanaka S., et al. (1995). C-type natriuretic peptide inhibits intimal thickening after vascular injury. Ann. N Y. Acad. Sci. 748 517\u2013523. 10.1111/j.1749-6632.1994.tb17352.x", "ArticleIdList": ["10.1111/j.1749-6632.1994.tb17352.x", "7695197"]}, {"Citation": "Gao J., Liu Y., Li Y. M. (2018). Review of risk factors, treatment, and prevention of saphenous vein graft disease after coronary artery bypass grafting. J. Int. Med. Res. 46 4907\u20134919. 10.1177/0300060518792445", "ArticleIdList": ["10.1177/0300060518792445", "PMC6300967", "30178686"]}, {"Citation": "Garaulet M., P\u00e9rez-Llamas F., Baraza J. C., Garcia-Prieto M. D., Fardy P. S., T\u00e9bar F. J., et al. (2002). Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. J. Nutr. Health Aging 6 123\u2013126.", "ArticleIdList": ["12166365"]}, {"Citation": "Gaudino M., Antoniades C., Benedetto U., Deb S., Di Franco A., Di Giammarco G., et al. (2017). Mechanisms, consequences, and prevention of coronary graft failure. Circulation 136 1749\u20131764. 10.1161/circulationaha.117.027597", "ArticleIdList": ["10.1161/circulationaha.117.027597", "29084780"]}, {"Citation": "Gentili A., Frangione M. R., Albini E., Vacca C., Ricci M. A., De Vuono S., et al. (2017). Modulation of natriuretic peptide receptors in human adipose tissue: molecular mechanisms behind the \u201cnatriuretic handicap\u201d in morbidly obese patients. Transl. Res. 186 52\u201361. 10.1016/j.trsl.2017.06.001", "ArticleIdList": ["10.1016/j.trsl.2017.06.001", "28651075"]}, {"Citation": "Gower W. R., Jr., Carter G. M., McAfee Q., Solivan S. M. (2006). Identification, regulation and anti-proliferative role of the NPR-C receptor in gastric epithelial cells. Mol. Cell. Biochem. 293 103\u2013118. 10.1007/s11010-006-9234-3", "ArticleIdList": ["10.1007/s11010-006-9234-3", "16786190"]}, {"Citation": "Hamzeh N., Ghadimi F., Farzaneh R., Hosseini S. K. (2017). Obesity, heart failure, and obesity paradox. J. Tehran. Heart Cent. 12 1\u20135.", "ArticleIdList": ["PMC5409942", "28469684"]}, {"Citation": "Hobbs A., Foster P., Prescott C., Scotland R., Ahluwalia A. (2004). Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation 110 1231\u20131235. 10.1161/01.Cir.0000141802.29945.34", "ArticleIdList": ["10.1161/01.Cir.0000141802.29945.34", "15337698"]}, {"Citation": "Horio T., Tokudome T., Maki T., Yoshihara F., Suga S., Nishikimi T., et al. (2003). Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 144 2279\u20132284.", "ArticleIdList": ["12746286"]}, {"Citation": "Houser S. R., Margulies K. B., Murphy A. M., Spinale F. G., Francis G. S., Prabhu S. D., et al. (2012). Animal models of heart failure: a scientific statement from the american heart association. Circ. Res. 111 131\u2013150. 10.1161/RES.0b013e3182582523", "ArticleIdList": ["10.1161/RES.0b013e3182582523", "22595296"]}, {"Citation": "Hu Q., Liu Q., Wang S., Zhen X., Zhang Z., Lv R., et al. (2016). NPR-C gene polymorphism is associated with increased susceptibility to coronary artery disease in chinese han population: a multicenter study. Oncotarget 7 33662\u201333674. 10.18632/oncotarget.9358", "ArticleIdList": ["10.18632/oncotarget.9358", "PMC5085110", "27191271"]}, {"Citation": "Huntley B. K., Ichiki T., Sangaralingham S. J., Chen H. H., Burnett J. C., Jr. (2010). B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts. J. Cell. Physiol. 225 251\u2013255. 10.1002/jcp.22253", "ArticleIdList": ["10.1002/jcp.22253", "PMC3835535", "20506274"]}, {"Citation": "Huntley B. K., Sandberg S. M., Noser J. A., Cataliotti A., Redfield M. M., Matsuda Y., et al. (2006). BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors. J. Cell. Physiol. 209 943\u2013949. 10.1002/jcp.20793", "ArticleIdList": ["10.1002/jcp.20793", "16986166"]}, {"Citation": "Hwang S. J., Melenovsky V., Borlaug B. A. (2014). Implications of coronary artery disease in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 63 2817\u20132827. 10.1016/j.jacc.2014.03.034", "ArticleIdList": ["10.1016/j.jacc.2014.03.034", "24768876"]}, {"Citation": "Janovska P., Melenovsky V., Svobodova M., Havlenova T., Kratochvilova H., Haluzik M., et al. (2020). Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin. J. Cachexia Sarcopenia Muscle 11 1614\u20131627. 10.1002/jcsm.12631", "ArticleIdList": ["10.1002/jcsm.12631", "PMC7749591", "33084249"]}, {"Citation": "Jansen H. J., Mackasey M., Moghtadaei M., Belke D. D., Egom E. E., Tuomi J. M., et al. (2018). Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation. J. Mol. Cell. Cardiol. 124 12\u201325. 10.1016/j.yjmcc.2018.09.011", "ArticleIdList": ["10.1016/j.yjmcc.2018.09.011", "30273558"]}, {"Citation": "Jansen H. J., Mackasey M., Moghtadaei M., Liu Y., Kaur J., Egom E. E., et al. (2019). NPR-C (natriuretic peptide receptor-C) modulates the progression of angiotensin II-mediated atrial fibrillation and atrial remodeling in mice. Circ. Arrhythm. Electrophysiol. 12:e006863. 10.1161/circep.118.006863", "ArticleIdList": ["10.1161/circep.118.006863", "30636477"]}, {"Citation": "Kapoor J. R., Heidenreich P. A. (2010). Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am. Heart J. 159 75\u201380. 10.1016/j.ahj.2009.10.026", "ArticleIdList": ["10.1016/j.ahj.2009.10.026", "20102870"]}, {"Citation": "Kapoun A. M., Liang F., O\u2019Young G., Damm D. L., Quon D., White R. T., et al. (2004). B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ. Res. 94 453\u2013461. 10.1161/01.RES.0000117070.86556.9F", "ArticleIdList": ["10.1161/01.RES.0000117070.86556.9F", "14726474"]}, {"Citation": "Katada T., Ui M. (1982). Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc. Natl. Acad. Sci. U S A 79 3129\u20133133.", "ArticleIdList": ["PMC346367", "6954463"]}, {"Citation": "Kawakami R., Saito Y., Kishimoto I., Harada M., Kuwahara K., Takahashi N., et al. (2004). Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction. Circulation 110 3306\u20133312. 10.1161/01.CIR.0000147829.78357.C5", "ArticleIdList": ["10.1161/01.CIR.0000147829.78357.C5", "15545516"]}, {"Citation": "Khambata R. S., Panayiotou C. M., Hobbs A. J. (2011). Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide. Br. J. Pharmacol. 164 584\u2013597. 10.1111/j.1476-5381.2011.01400.x", "ArticleIdList": ["10.1111/j.1476-5381.2011.01400.x", "PMC3178781", "21457229"]}, {"Citation": "Kirkman D. L., Bohmke N., Billingsley H. E., Carbone S. (2020). Sarcopenic obesity in heart failure with preserved ejection fraction. Front. Endocrinol. 11:558271. 10.3389/fendo.2020.558271", "ArticleIdList": ["10.3389/fendo.2020.558271", "PMC7561426", "33117276"]}, {"Citation": "Kishimoto I., Yoshimasa T., Suga S., Ogawa Y., Komatsu Y., Nakagawa O., et al. (1994). Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells. J. Biol. Chem. 269 28300\u201328308.", "ArticleIdList": ["7961768"]}, {"Citation": "Kitzman D. W., Shah S. J. (2016). The HFpEF obesity phenotype: the elephant in the room. J. Am. Coll. Cardiol. 68 200\u2013203. 10.1016/j.jacc.2016.05.019", "ArticleIdList": ["10.1016/j.jacc.2016.05.019", "27386774"]}, {"Citation": "Kovacova Z., Tharp W. G., Liu D., Wei W., Xie H., Collins S., et al. (2016). Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obesity (Silver Spring) 24 820\u2013828. 10.1002/oby.21418", "ArticleIdList": ["10.1002/oby.21418", "PMC5067565", "26887289"]}, {"Citation": "Kragelund C., Omland T. (2005). A farewell to body-mass index? Lancet 366 1589\u20131591. 10.1016/s0140-6736(05)67642-8", "ArticleIdList": ["10.1016/s0140-6736(05)67642-8", "16271629"]}, {"Citation": "Kuhn M., Voss M., Mitko D., Stypmann J., Schmid C., Kawaguchi N., et al. (2004). Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc. Res. 64 308\u2013314. 10.1016/j.cardiores.2004.07.004", "ArticleIdList": ["10.1016/j.cardiores.2004.07.004", "15485690"]}, {"Citation": "Litwin S. E. (2008). Which measures of obesity best predict cardiovascular risk? J. Am. Coll. Cardiol. 52 616\u2013619. 10.1016/j.jacc.2008.05.017", "ArticleIdList": ["10.1016/j.jacc.2008.05.017", "18702963"]}, {"Citation": "Mackasey M., Egom E. E., Jansen H. J., Hua R., Moghtadaei M., Liu Y., et al. (2018). Natriuretic peptide receptor-c protects against angiotensin II-mediated sinoatrial node disease in mice. JACC Basic Transl. Sci. 3 824\u2013843. 10.1016/j.jacbts.2018.08.004", "ArticleIdList": ["10.1016/j.jacbts.2018.08.004", "PMC6314975", "30623142"]}, {"Citation": "Mahabadi A. A., Berg M. H., Lehmann N., K\u00e4lsch H., Bauer M., Kara K., et al. (2013). Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the heinz nixdorf recall study. J. Am. Coll. Cardiol. 61 1388\u20131395. 10.1016/j.jacc.2012.11.062", "ArticleIdList": ["10.1016/j.jacc.2012.11.062", "23433560"]}, {"Citation": "Matsukawa N., Grzesik W. J., Takahashi N., Pandey K. N., Pang S., Yamauchi M., et al. (1999). The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. U S A 96 7403\u20137408. 10.1073/pnas.96.13.7403", "ArticleIdList": ["10.1073/pnas.96.13.7403", "PMC22098", "10377427"]}, {"Citation": "Matter C. M., Rozenberg I., Jaschko A., Greutert H., Kurz D. J., Wnendt S., et al. (2006). Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells. J. Cardiovasc. Pharmacol. 48 286\u2013292. 10.1097/01.fjc.0000248233.22570.8b", "ArticleIdList": ["10.1097/01.fjc.0000248233.22570.8b", "17204907"]}, {"Citation": "McKavanagh P., Yanagawa B., Zawadowski G., Cheema A. (2017). Management and prevention of saphenous vein graft failure: a review. Cardiol. Ther. 6 203\u2013223. 10.1007/s40119-017-0094-6", "ArticleIdList": ["10.1007/s40119-017-0094-6", "PMC5688971", "28748523"]}, {"Citation": "Modi K., Soos M. P., Mahajan K. (2021). \u201dStent Thrombosis,\u201d in StatPearls. Treasure Island, FL: StatPearls Publishing LLC.", "ArticleIdList": ["28722937"]}, {"Citation": "Mohammed S. F., Hussain S., Mirzoyev S. A., Edwards W. D., Maleszewski J. J., Redfield M. M. (2015). Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 131 550\u2013559. 10.1161/circulationaha.114.009625", "ArticleIdList": ["10.1161/circulationaha.114.009625", "PMC4324362", "25552356"]}, {"Citation": "Moreno-Santos I., Mac\u00edas-Gonz\u00e1lez M., Porras-Mart\u00edn C., Castellano-Castillo D., S\u00e1nchez-Esp\u00edn G., G\u00f3mez-Doblas J. J., et al. (2019). Role of epicardial adipose tissue NPR-C in acute coronary syndrome. Atherosclerosis 286 79\u201387. 10.1016/j.atherosclerosis.2019.05.010", "ArticleIdList": ["10.1016/j.atherosclerosis.2019.05.010", "31102956"]}, {"Citation": "Mudd J. O., Kass D. A. (2008). Tackling heart failure in the twenty-first century. Nature 451 919\u2013928.", "ArticleIdList": ["18288181"]}, {"Citation": "Nakanishi K., Fukuda S., Tanaka A., Otsuka K., Jissho S., Taguchi H., et al. (2014). Persistent epicardial adipose tissue accumulation is associated with coronary plaque vulnerability and future acute coronary syndrome in non-obese subjects with coronary artery disease. Atherosclerosis 237 353\u2013360. 10.1016/j.atherosclerosis.2014.09.015", "ArticleIdList": ["10.1016/j.atherosclerosis.2014.09.015", "25310459"]}, {"Citation": "Nakatsuji H., Maeda N., Hibuse T., Hiuge A., Hirata A., Kuroda Y., et al. (2010). Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells. Biochem. Biophys. Res. Commun. 392 100\u2013105. 10.1016/j.bbrc.2010.01.008", "ArticleIdList": ["10.1016/j.bbrc.2010.01.008", "20059960"]}, {"Citation": "Naruko T., Itoh A., Haze K., Ehara S., Fukushima H., Sugama Y., et al. (2005). C-Type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. Atherosclerosis 181 241\u2013250. 10.1016/j.atherosclerosis.2005.01.023", "ArticleIdList": ["10.1016/j.atherosclerosis.2005.01.023", "16039277"]}, {"Citation": "\u00d1ato M., Gomez-Lara J., Romaguera R., Roura G., Ferreiro J. L., Teruel L., et al. (2018). One-year optical coherence tomography findings in patients with late and very-late stent thrombosis treated with intravascular imaging guided percutaneous coronary intervention. Int. J. Cardiovasc. Imag. 34 1511\u20131520. 10.1007/s10554-018-1372-7", "ArticleIdList": ["10.1007/s10554-018-1372-7", "29790037"]}, {"Citation": "Nattel S. (2002). New ideas about atrial fibrillation 50 years on. Nature 415 219\u2013226. 10.1038/415219a", "ArticleIdList": ["10.1038/415219a", "11805846"]}, {"Citation": "Ndumele C. E., Matsushita K., Lazo M., Bello N., Blumenthal R. S., Gerstenblith G., et al. (2016). Obesity and subtypes of incident cardiovascular disease. J. Am. Heart Assoc. 5:e003921. 10.1161/jaha.116.003921", "ArticleIdList": ["10.1161/jaha.116.003921", "PMC5015307", "27468925"]}, {"Citation": "Neumann F. J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A. P., Benedetto U., et al. (2019a). 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 40 87\u2013165. 10.1093/eurheartj/ehy394", "ArticleIdList": ["10.1093/eurheartj/ehy394", "30165437"]}, {"Citation": "Neumann F. J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A. P., Benedetto U., et al. (2019b). [2018 ESC/EACTS guidelines on myocardial revascularization. The task force on myocardial revascularization of the european society of cardiology (ESC) and european association for cardio-thoracic surgery (EACTS)]. G. Ital. Cardiol. (Rome) 20 1s\u201361s. 10.1714/3203.31801", "ArticleIdList": ["10.1714/3203.31801", "31379378"]}, {"Citation": "Nishikido T., Oyama J. I., Nagatomo D., Node K. (2019). A reduction of BMI predicts the risk of rehospitalization and cardiac death in non-obese patients with heart failure. Int. J. Cardiol. 276 166\u2013170. 10.1016/j.ijcard.2018.08.054", "ArticleIdList": ["10.1016/j.ijcard.2018.08.054", "30139701"]}, {"Citation": "Nishimura M., Brann A., Chang K. W., Maisel A. S. (2018). The confounding effects of non-cardiac pathologies on the interpretation of cardiac biomarkers. Curr. Heart Fail. Rep. 15 239\u2013249. 10.1007/s11897-018-0398-4", "ArticleIdList": ["10.1007/s11897-018-0398-4", "29987498"]}, {"Citation": "Obokata M., Reddy Y. N. V., Pislaru S. V., Melenovsky V., Borlaug B. A. (2017). Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 136 6\u201319. 10.1161/circulationaha.116.026807", "ArticleIdList": ["10.1161/circulationaha.116.026807", "PMC5501170", "28381470"]}, {"Citation": "Oh A., Okazaki R., Sam F., Valero-Mu\u00f1oz M. (2019). Heart failure with preserved ejection fraction and adipose tissue: a story of two tales. Front. Cardiovasc. Med. 6:110. 10.3389/fcvm.2019.00110", "ArticleIdList": ["10.3389/fcvm.2019.00110", "PMC6687767", "31428620"]}, {"Citation": "Ohori K., Yano T., Katano S., Kouzu H., Honma S., Shimomura K., et al. (2021). High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox. BMC Geriatr. 21:16. 10.1186/s12877-020-01950-9", "ArticleIdList": ["10.1186/s12877-020-01950-9", "PMC7789382", "33407196"]}, {"Citation": "Owan T. E., Hodge D. O., Herges R. M., Jacobsen S. J., Roger V. L., Redfield M. M. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355 251\u2013259. 10.1056/NEJMoa052256", "ArticleIdList": ["10.1056/NEJMoa052256", "16855265"]}, {"Citation": "Padwal R., McAlister F. A., McMurray J. J., Cowie M. R., Rich M., Pocock S., et al. (2014). The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int. J. Obes. 38 1110\u20131114. 10.1038/ijo.2013.203", "ArticleIdList": ["10.1038/ijo.2013.203", "24173404"]}, {"Citation": "Paulus W. J., Tsch\u00f6pe C. (2013). A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 62 263\u2013271. 10.1016/j.jacc.2013.02.092", "ArticleIdList": ["10.1016/j.jacc.2013.02.092", "23684677"]}, {"Citation": "Pereira N. L., Redfield M. M., Scott C., Tosakulwong N., Olson T. M., Bailey K. R., et al. (2014). A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study. PloS one 9:e85708. 10.1371/journal.pone.0085708", "ArticleIdList": ["10.1371/journal.pone.0085708", "PMC3899045", "24465655"]}, {"Citation": "Potter L. R. (2011). Natriuretic peptide metabolism, clearance and degradation. Febs J. 278 1808\u20131817. 10.1111/j.1742-4658.2011.08082.x", "ArticleIdList": ["10.1111/j.1742-4658.2011.08082.x", "PMC4495883", "21375692"]}, {"Citation": "Roll\u00edn R., Mediero A., Fern\u00e1ndez-Cruz A., Fern\u00e1ndez-Durango R. (2005). Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat. Mol. Vis. 11 216\u2013224.", "ArticleIdList": ["15789000"]}, {"Citation": "Sarzani R., Spannella F., Giulietti F., Balietti P., Cocci G., Bordicchia M. (2017). Cardiac natriuretic peptides, hypertension and cardiovascular risk. High Blood Press. Cardiovasc. Prev. 24 115\u2013126. 10.1007/s40292-017-0196-1", "ArticleIdList": ["10.1007/s40292-017-0196-1", "PMC5440492", "28378069"]}, {"Citation": "Sarzani R., Strazzullo P., Salvi F., Iacone R., Pietrucci F., Siani A., et al. (2004). Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. Obes. Res. 12 351\u2013356. 10.1038/oby.2004.44", "ArticleIdList": ["10.1038/oby.2004.44", "14981229"]}, {"Citation": "Scotland R. S., Ahluwalia A., Hobbs A. J. (2005). C-type natriuretic peptide in vascular physiology and disease. Pharmacol. Ther. 105 85\u201393. 10.1016/j.pharmthera.2004.08.011", "ArticleIdList": ["10.1016/j.pharmthera.2004.08.011", "15670620"]}, {"Citation": "Seferovic P. M., Ponikowski P., Anker S. D., Bauersachs J., Chioncel O., Cleland J. G. F., et al. (2019). Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the heart failure association of the european society of cardiology. Eur. J. Heart Fail. 21 1169\u20131186. 10.1002/ejhf.1531", "ArticleIdList": ["10.1002/ejhf.1531", "31129923"]}, {"Citation": "Shah S. J. (2010). Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease. Curr. Treat Options Cardiovasc. Med. 12 58\u201375. 10.1007/s11936-009-0060-2", "ArticleIdList": ["10.1007/s11936-009-0060-2", "20842482"]}, {"Citation": "Shah S. J., Kitzman D. W., Borlaug B. A., van Heerebeek L., Zile M. R., Kass D. A., et al. (2016). Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134 73\u201390. 10.1161/circulationaha.116.021884", "ArticleIdList": ["10.1161/circulationaha.116.021884", "PMC4930115", "27358439"]}, {"Citation": "Sousa-Uva M., Neumann F. J., Ahlsson A., Alfonso F., Banning A. P., Benedetto U., et al. (2019). 2018 ESC/EACTS guidelines on myocardial revascularization. Eur. J. Cardiothorac. Surg. 55 4\u201390. 10.1093/ejcts/ezy289", "ArticleIdList": ["10.1093/ejcts/ezy289", "30165632"]}, {"Citation": "Stavrakis S., Pakala A., Thomas J., Chaudhry M. A., Thadani U. (2013). Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am. J. Med. Sc.i 345 211\u2013217. 10.1097/MAJ.0b013e318271c012", "ArticleIdList": ["10.1097/MAJ.0b013e318271c012", "23422653"]}, {"Citation": "Swaminathan P. D., Purohit A., Soni S., Voigt N., Singh M. V., Glukhov A. V., et al. (2011). Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J. Clin. Invest. 121 3277\u20133288. 10.1172/JCI57833", "ArticleIdList": ["10.1172/JCI57833", "PMC3223923", "21785215"]}, {"Citation": "Sweeney M., Corden B., Cook S. A. (2020). Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? EMBO Mol. Med. 12:e10865. 10.15252/emmm.201910865", "ArticleIdList": ["10.15252/emmm.201910865", "PMC7539225", "32955172"]}, {"Citation": "Thomas E., Gupta P. P., Fonarow G. C., Horwich T. B. (2019). Bioelectrical impedance analysis of body composition and survival in patients with heart failure. Clin. Cardiol. 42 129\u2013135. 10.1002/clc.23118", "ArticleIdList": ["10.1002/clc.23118", "PMC6436517", "30447075"]}, {"Citation": "Tromp J., Shen L., Jhund P. S., Anand I. S., Carson P. E., Desai A. S., et al. (2019). Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 74 601\u2013612. 10.1016/j.jacc.2019.05.052", "ArticleIdList": ["10.1016/j.jacc.2019.05.052", "31370950"]}, {"Citation": "Tsuruda T., Boerrigter G., Huntley B. K., Noser J. A., Cataliotti A., Costello-Boerrigter L. C., et al. (2002). Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ. Res. 91 1127\u20131134.", "ArticleIdList": ["12480813"]}, {"Citation": "Upadhya B., Kitzman D. W. (2017). Heart failure with preserved ejection fraction in older adults. Heart Fail. Clin. 13 485\u2013502. 10.1016/j.hfc.2017.02.005", "ArticleIdList": ["10.1016/j.hfc.2017.02.005", "PMC5546159", "28602367"]}, {"Citation": "Valero-Mu\u00f1oz M., Backman W., Sam F. (2017). Murine models of heart failure with preserved ejection fraction: a \u201cfishing expedition\u201d. JACC Basic Transl. Sci. 2 770\u2013789. 10.1016/j.jacbts.2017.07.013", "ArticleIdList": ["10.1016/j.jacbts.2017.07.013", "PMC5764178", "29333506"]}, {"Citation": "Vermond R. A., Geelhoed B., Verweij N., Tieleman R. G., Van der Harst P., Hillege H. L., et al. (2015). Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the netherlands. J. Am. Coll. Cardiol. 66 1000\u20131007. 10.1016/j.jacc.2015.06.1314", "ArticleIdList": ["10.1016/j.jacc.2015.06.1314", "26314526"]}, {"Citation": "Wakisaka O., Takahashi N., Shinohara T., Ooie T., Nakagawa M., Yonemochi H., et al. (2007). Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72. J. Mol. Cell. Cardiol. 43 616\u2013626. 10.1016/j.yjmcc.2007.08.005", "ArticleIdList": ["10.1016/j.yjmcc.2007.08.005", "17884089"]}, {"Citation": "Wei C. M., Hu S., Miller V. M., Burnett J. C., Jr. (1994). Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 205 765\u2013771. 10.1006/bbrc.1994.2731", "ArticleIdList": ["10.1006/bbrc.1994.2731", "7999110"]}, {"Citation": "Yuan K., Kim S. Y., Oh Y. B., Yu J., Shah A., Park B. H., et al. (2010). Upregulation of ANP and NPR-C mRNA in the kidney and heart of eNOS knockout mice. Peptides 31 1319\u20131325. 10.1016/j.peptides.2010.04.008", "ArticleIdList": ["10.1016/j.peptides.2010.04.008", "20403400"]}, {"Citation": "Zayed M. A., Harring S. D., Abendschein D. R., Vemuri C., Lu D., Detering L., et al. (2016). Natriuretic peptide receptor-C is up-regulated in the intima of advanced carotid artery atherosclerosis. J. Med. Surg. Pathol. 1:131. 10.4172/2472-4971.1000131", "ArticleIdList": ["10.4172/2472-4971.1000131", "PMC4989919", "27547837"]}, {"Citation": "Zhou H., Murthy K. S. (2003). Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am. J. Physiol. Cell. Physiol. 284 C1255\u2013C1261. 10.1152/ajpcell.00520.2002", "ArticleIdList": ["10.1152/ajpcell.00520.2002", "12676657"]}, {"Citation": "Zile M. R., Baicu C. F., Gaasch W. H. (2004). Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 350 1953\u20131959. 10.1056/NEJMoa032566", "ArticleIdList": ["10.1056/NEJMoa032566", "15128895"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "1"}, {"Year": "2021", "Month": "4", "Day": "12"}, {"Year": "2021", "Month": "6", "Day": "7", "Hour": "5", "Minute": "49"}, {"Year": "2021", "Month": "6", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["34093235", "PMC8176210", "10.3389/fphys.2021.674254"]}}], "PubmedBookArticle": []}